Medical establishments were unprepared for HIV/AIDS when it emerged in the early 1980s, government agencies were reluctant to act, and social stigma silenced many in need. An extraordinary woman worked behind the scenes to build a global scientific framework while activists called for emergency action: Dr. Mathilde Krim.
Krim was a distinguished geneticist and cancer researcher as well as a prominent Manhattan philanthropist with access to Hollywood stars, corporate leaders, and politicians of note. Instead of remaining comfortable within elite social circles, she channeled her influence, expertise, and fortune into a relentless campaign against the new disease.
After co-founding the AIDS Medical Foundation and the American Foundation for AIDS Research (amfAR), she created the first independent, non-profit foundation dedicated to funding cutting-edge HIV research, promoting needle exchange programs, and eliminating social stigma associated with the disease.
We combine rigorous biomedical science with high-society philanthropy to combat the global health crisis. From European genetics research to global AIDS advocacy, we will examine the extraordinary life of Mathilde Krim in this detailed exploration.
From European resistance to biomedical science: the early years
Mathilde Galland was born on July 9, 1926, in Como, Italy, to an Austrian mother and a Swiss-Italian father. As a child, she was raised in a multilingual, cultured household that valued intellectual rigor and social responsibility.
Mathilde was acutely aware of the horrors taking place across Europe during World War II as she lived in neutral Switzerland. Due to stories of persecution and suffering, she secretly assisted members of the Jewish underground resistance operating in Europe, smuggling supplies and messages.
Genetics as an academic pursuit
She studied genetics and biology at the University of Geneva after the war. She earned her doctorate in gene morphology and cytogenetics in 1953, a remarkable achievement for a woman during the mid-twentieth century.
To contribute directly to human health, she moved to Israel to join the research team at the world-renowned Weizmann Institute of Science.
Krim studied prenatal genetics and cancer biology at the Weizmann Institute between 1953 and 1959:
- Amniocentesis Data Pioneer: She contributed to the development of early techniques for determining fetal sex through amniotic fluid analysis, laying the foundation for modern prenatal diagnostics.
- Virology of cancer: She developed expertise in human immunology and viral biology that would prove crucial decades later.
The New Yorker’s Guide to Science in High Society
Mathilde Krim married Arthur B. Krim, a wealthy New York attorney and prominent Hollywood film executive who served as the Democratic National Party’s finance chairman in 1958.
Mathilde Krim joined the Cornell University Medical College’s research staff and later accepted a position at the Memorial Sloan-Kettering Cancer Center, one of the world’s foremost cancer centers.
During her time at Sloan-Kettering, Krim specialized in interferon, a protein naturally produced by immune cells to fight viral infections and tumors. By establishing the Interferon Laboratory at the institute, she became one of the leading international advocates for the use of interferon as a non-toxic cancer treatment.
Living Room of a Power Broker
In addition to managing her laboratory by day, Krim hosted political fundraisers, Hollywood elites, and civil rights leaders in her Manhattan townhouse by night. During the Kennedy and Johnson administrations, Arthur and Mathilde Krim were close advisors to the presidents.
Their social circle included major cultural figures like Elizabeth Taylor and Barbra Streisand, as well as prominent business leaders. With her unique combination of qualities, Krim was able to debate cellular genetics with Nobel laureate scientists in the morning and convince billionaire philanthropists or US senators to support social causes in the evening.
An Arriving Storm: How to Spot the Early Warning Signs
The first cases of Kaposi’s sarcoma and unusual opportunistic infections were reported among young gay men in New York and California in 1981.
Using her background in cancer virology and immunology, Krim recognized the pattern immediately. An unknown infectious agent destroyed the human immune system’s helper T-cells, leaving patients completely defenseless against common environmental pathogens.
Krim acted with urgency while government health agencies hesitated to allocate research funds due to the political sensitivity of the disease:
- Seeing the stigma: She observed colleagues in major hospitals treating dying patients with fear, hesitation, and prejudice.
- Understanding Funding Gaps: Traditional government funding bodies require lengthy reviews of research grants before they can be released. This delays patients who are facing a fast-moving virus from being able to obtain medical care.
- Taking action over silence: Krim risked her academic status and social reputation to confront the health crisis.
The Birth of amfAR: Building an Independent Scientific Engine
Dr. Joseph Sonnabend and Krim formed the AIDS Medical Foundation in 1983, using their own personal funds to lease and hire office space and staff. The organization was the first to raise research funds solely for AIDS research.
Following the death of Rock Hudson, Krim realized the disease required a national and international strategy, so he joined forces with Hollywood icon Elizabeth Taylor to fight it.
As a result of their merger, the American Foundation for AIDS Research, commonly called amfAR, was formed.
AmfAR’s Impact on Biomedical Funding
Krim pioneered a nimble, highly efficient funding model that bypassed red tape under his leadership as founding co-chair and later chairman of the board:
- Seed Grants: AmfAR funded young scientists to test unconventional ideas with small, rapid grants. Early funding allowed researchers to gather preliminary data that would later help them secure larger, permanent government grants.
- Investing in key monoclonal studies: Early amfAR grants funded fundamental research into how HIV attaches to CD4 receptors on immune cells. This research eventually led to the development of modern antiretroviral drugs.
- Needle Exchange Programs: AmfAR funded needle exchange research directly when the federal government banned funding for clean needle exchange programs, proving scientifically that needle exchange programs significantly reduced HIV transmission among intravenous drug users without increasing drug abuse.
Activism, Hollywood, and Capitol Hill: Bridging the Gap
She was able to bring vastly different worlds together in a unified campaign that was one of Mathilde Krim’s greatest historical achievements.
As tensions between street activists like ACT UP and federal health officials reached extreme levels in the late 1980s, Krim played an important role as a bridge between the two groups. The activists trusted her because she spoke openly about civil liberties, human rights, and needle exchange programs without judgment. In addition to being an accomplished scientist, she was married to an influential political insider, so she was highly respected by government officials and corporate donors.
Glamour for a Deadly Cause in Hollywood
As a result of her personal friendship with Elizabeth Taylor, Krim leveraged high-society galas into massive fundraising events.
In Cannes and New York, amfAR galas became major international social events. The event generated tens of millions of dollars for scientific research while promoting discussion on HIV prevention and treatment among film stars, fashion designers, and corporate titans.
Replying to a congressional inquiry
While teaching politicians about viral biology and human rights, Krim walked the halls of the U.S. Capitol for countless hours.
In her testimony before congressional committees, she was sharp, polite, and uncompromising. The congresswoman repeatedly reminded lawmakers that viruses do not discriminate based on sexual orientation, lifestyle, or national origin, arguing that public health policies based on moral judgments are doomed to fail.
Contributions and lasting impacts
During the past three decades, Mathilde Krim has served as the moral and scientific compass of global AIDS philanthropy. Through her leadership, structural changes were made to the way public health crises are handled:
- De-stigmatizing the Disease: Krim mobilized celebrities, corporate leaders, and former presidents to make HIV/AIDS a mainstream public health concern.
- Establishing Independent Scientific Funding: She proved that non-profit foundations could act more rapidly than federal bureaucracies, setting a template for modern medical foundations that fight cancer, rare genetic disorders, and neurodegenerative diseases.
- Advancing harm reduction: She championed clean needle exchange programs and public sex education as evidence-based strategies in modern public health.
- Awarded the Presidential Medal of Freedom: President Bill Clinton awarded Mathilde Krim the highest civilian honor given by the United States in 2000 for her outstanding courage, scientific leadership, and humanitarian efforts.
The final thoughts of a courageous and compassionate man
Mathilde Krim, 91, passed away at her Kings Point, New York, home on January 15, 2018.
The story of her life illustrates how scientific expertise, social privilege, and deep moral courage can change the course of human history. She lent her voice, her laboratory experience, and her social influence at a time when fear and prejudice threatened to derail medical progress.
She did more than raise over $500 million for biomedical research through amfAR, she restored human dignity to millions who faced a deadly epidemic as a result of her decades of advocacy.
She continues to leave a legacy every time a medical grant is awarded, every time a public health policy prioritizes compassion over judgment, and every time science is used to protect human life.
